KZA Media Thread, page-962

Well...171 pages and no mention of drugs in development, only those recently given FDA final approval. I sped-red the thing. Their conclusion was:

THEREFORE, THEAACR URGES CONGRESS TO:Continue to support robust, sustained, and predictable growth for the NIH and NCI by providing increases in their FY2021 base budgets of at least $3 billion and $522 million, respectively, for a total funding level of $44.7 billion for the NIH and $6.9 billion for the NCI.Ensure that the $195 million in funding designated through the 21st Century Cures Act for targeted initiatives, including the National Cancer Moonshot, is fully appropriated in FY2021 and is supplemental to the overall increase in the NIH base budget.Support the FDA’s critical regulatory science initiatives by providing an increase of at least $120 million in discretionary budget authority in FY 2021.Support the CDC Cancer Prevention and Control Programs with total funding of at least $559 million. This includes funding for comprehensive cancer control, cancer registries, and screening and awareness programs for specific cancers.■ Continue to support appropriation bills that include increased funding for CDC’s Office of Smoking and Health, to continue to strengthen comprehensive tobacco prevention and control programs.■ Provide $50 million for the second year of the Childhood Cancer Data Initiative and “no less than” $25 million for the continued implementation of the Childhood Cancer STAR Act.■ Exempt NIH and other key public health agencies from the highly restrictive FY 2021 budget caps to allow them to forcefully respond to the COVID-19 health crisis,as well as to support the science that is necessary to improve and save lives from the myriad of diseases faced by Americans and by people all over the world.■ Eliminate the pervasive racial biases in the conduct of cancer research that have led to significant inequities in cancer care, low participation for minorities in clinical trials, and an underrepresentation of racial and ethnic minority scientists in the cancer research workforceby supporting a congressional effort that calls on the National Academies of Science, Engineering, and Medicine to undertake a study to assess systemic racism in academia.The COVID-19 pandemic is one of the greatest health crises that this country has ever faced, leading to thousands of lives lost, an economy thrown into chaos, and significant alterations in everyday life for millions of Americans.The pandemic has also highlighted the vital importanceof medical research. Across the country, funding for ongoing medical research was diverted to stop the spread of COVID-19 and to expeditiously develop vaccines and treatments for this unprecedented disease.In the face of the current health crisis due to the COVID-19 pandemic, cancer and other diseases continue to be major ongoing challenges. If we hope to reach the day when cancer is no longer a major health threat toour nation’s citizens, Congress must provide the critical funding that is essential for research supported by the NIH and NCI. By providing robust, sustained, and predictable annual funding increases for the NIH and NCI in FY 2021 and beyond, Congress will acceleratethe pace at which we make future scientific advances, capitalize on prior investments in cancer research, spur innovation and economic prosperity for our country,and bring lifesaving cures to many patients in the United States and around the world.